Parkinson’s Disease – Pipeline Review, H2 2016’, provides an overview of the Parkinson’s Disease pipeline landscape- ken Research


Global Markets Direct’s, ‘Parkinson’s Disease – Pipeline Review, H2 2016’, provides an overview of the Parkinson’s Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Parkinson’s Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Parkinson’s Disease and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.


The report provides a snapshot of the global therapeutic landscape of Parkinson’s Disease

The report reviews pipeline therapeutics for Parkinson’s Disease by companies and universities/research institutes based on information derived from company and industry-specific sources

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved Parkinson’s Disease therapeutics and enlists all their major and minor projects

The report assesses Parkinson’s Disease therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news related to pipeline therapeutics for Parkinson’s Disease

Reasons to Buy

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Parkinson’s Disease

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Parkinson’s Disease pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Topics Covered in The Report

  • Global Parkinson Disease Market Research,
  • Global Parkinson Disease Market Trends,
  • Global Parkinson Disease Market Share,
  • Global Parkinson Disease Market Growth,
  • Global Parkinson Disease Market Future,
  • Parkinson Disease Therapeutics Market analysis,
  • Parkinson Disease Therapeutics Market Developments,
  • Parkinson Disease Therapeutics Market Companies Revenue,
  • Global Parkinson Disease Market Outlook,
  • Global Parkinson Disease Industry Size,
  • Global Parkinson Disease Market Analysis,
  • Global Parkinson Disease Market Forecast,
  • Global Parkinson Disease Future Projections,
  • Parkinson Disease pipeline landscape,
  • Parkinson Disease Therapeutics Market,
  • Global Parkinson Drugs Market,
  • Parkinson Disease Market,

For More Coverage Click On The Link Below:

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications



Comments are closed.